MBI proves more cost effective than other imaging modalities in Breast Cancer diagnosis as a secondary screening tool to Mammography in women with Dense Breasts – Mayo Clinic

Molecular Breast Imaging Solutions was established with the belief that everyone deserves access to improved health outcomes.

We have partnered with Evo Worldwide in order to make the GE Discovery NM750b Molecular Breast Imaging System available to Medical Professionals and their patients throughout Australia and New Zealand.

MBIS believes passionately in this technologically-advanced and cost effective imaging modality and its potential for

improved breast cancer diagnosis.

MBI is a safe, reliable and comfortable solution for Breast Cancer detection in women with Dense Breast Tissue who are at higher risk for developing Breast Cancer

HIGHLY SENSTIVE IMAGING FOR DENSE BREASTS

GE DISCOVERY NM 750b

COMmITTED TO THE FIGHT AGAINST BREAST CANCER

REDUCED BIOPSIES

The addition of MBI to screening mammography leads to the detection of almost 4 times more cancers than mammography alone

– Mayo Clinic

Web Design by Alloy Media.

Molecular Breast Imaging

MBI leads to a lower rate of negative (unnecessary)biopsies compared to other supplemental screening techniques

– Mayo Clinic

The Discovery NM750b boasts High Sensitivity and Specificity using Direct Conversion Technology with dual CZT detectors designed to acquire images analogous to Mammography.